Drug Trial Radar · NCT07533019
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
66
Planned (sponsor's estimate)
Start
Apr 14, 2026
Primary completion
May 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study will last approximately 48 weeks, including screening.
Conditions
- Vitiligo
- Non-Segmental Vitiligo (NSV)
Interventions
LY4005130Drug
Administered IV
PlaceboDrug
Administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Facial Vitiligo Area Scoring Index (F-VASI) 75Time frame: Week 24
Locations
35 sites in 5 countries. Site status is shown where the registry gives one.
Medical Dermatology Specialists
Phoenix, Arizona · Recruiting
Saguaro Dermatology - Phoenix
Phoenix, Arizona · Recruiting
Center For Dermatology Clinical Research, Inc.
Fremont, California · Recruiting
Northridge Clinical Trials
Northridge, California · Recruiting
Cura Clinical Research - Oxnard
Oxnard, California · Recruiting
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway
Santa Clarita, California · Recruiting
Health Clinical Research, LLC
Miami, Florida · Recruiting
K2 Medical Research - Tampa
Tampa, Florida · Recruiting
Advanced Medical Research, PC.
Sandy Springs, Georgia · Recruiting
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Revival Research Institute, LLC
Troy, Michigan · Recruiting
Stracskin
Portsmouth, New Hampshire · Recruiting
Equity Medical
The Bronx, New York · Recruiting
Accurate Clinical Research, Inc
Humble, Texas · Recruiting
Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue
San Antonio, Texas · Recruiting
Jordan Valley Dermatology & Research Center
South Jordan, Utah · Recruiting
Clinical Research Partners, LLC
Richmond, Virginia · Recruiting
Anima Diepenbeek
Diepenbeek, Belgium · Recruiting
UZ Gent
Ghent, Belgium · Recruiting
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman
Liège, Belgium · Recruiting
INTERMED Groupe Sante
Chicoutimi, Canada · Recruiting
DermEffects
London, Canada · Recruiting
Dar Clinical Research - Ottawa - Hunt Club Road
Ottawa, Canada · Recruiting
The Centre for Dermatology
Richmond Hill, Canada · Recruiting
Research Toronto
Toronto, Canada · Recruiting
SIMa Recherche
Verdun, Canada · Recruiting
Peking University People's Hospital
Beijing, China · Recruiting
Hangzhou Third People's Hospital
Hangzhou, China · Recruiting
Shanghai Skin Disease Hospital
Shanghai, China · Recruiting
The University of Hong Kong-Shenzhen Hospital
Shenzhen, China · Recruiting
Centrum Badan Klinicznych PI-House sp. z o.o.
Gdansk, Poland · Recruiting
Diamond Clinic
Krakow, Poland · Recruiting
Dermedic Jacek Zdybski
Ostrowiec Świętokrzyski, Poland · Recruiting
Centrum Medyczne Ginemedica
Wroclaw, Poland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.